Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christina, Ruhlmann"'
Autor:
Michael Weichenthal, Inge Marie Svane, Johanna Mangana, Ulrike Leiter, Friedegund Meier, Christina Ruhlmann, Dimitrios Ziogas, Reinhard Dummer, Pablo Cerenzuela, Jose Luis Manzano, Marc Bender, Shan Jiang, Paolo Antonio Ascierto, Iva Gavrilova, Lidija Kandolf, Helen Gogas, Peter Mohr, Dirk Schadendorf, Eva Ellebaek
Publikováno v:
EJC Skin Cancer, Vol 2, Iss , Pp 100271- (2024)
Background: Postoperative treatment of patients with either BRAF/MEK inhibitors or anti-PD1 antibodies in the adjuvant setting results in improved recurrence free survival and has therefore become a standard of care for most patients with resected st
Externí odkaz:
https://doaj.org/article/6497af80a5374a6f94e7a339168a3441
Autor:
Christina Ruhlmann, Jørn Herrstedt
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2009, Iss default, Pp 375-384 (2009)
Christina Ruhlmann, Jørn HerrstedtOdense University Hospital, Department of Oncology, Odense, DenmarkAbstract: Chemotherapy-induced nausea and vomiting (CINV) are among the most feared and distressing symptoms experienced by patients with cancer. Th
Externí odkaz:
https://doaj.org/article/eae8ba13fdaf4a14bf811b8717eb9cc3
Publikováno v:
Ugeskrift for laeger. 181(32)
This review summarizes the current knowledge of radiation-induced nausea and vomiting (RINV), which occurs in ap-proximately 50% of patients undergoing radiotherapy. Poor control of the symptoms may result in dehydration and electrolyte disturbances
Publikováno v:
Ugeskrift for laeger. 181(27)
Nausea and vomiting are a persistent burden on cancer patients undergoing antineoplastic therapy, and adherence to guideline-specific prophylactic therapy is essential to minimise the risk. Nausea is more challenging to prevent than vomiting. This re